Series A startup

Who invested in Hera

2 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Raised 5 months ago

Funding summaryUpdated 26 Oct 2026

$29Mraised across 2 rounds since 2021, from 2 sources

$1.7MSeed$27MSeries A
Latest round
Series A, $27MJun 2026
Step-upi
15.9×
Investors
7
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20222023202420252026
$1.7MSeed$27MSeries A
First round
Seed, $1.7M
Oct 2021
Biggest round
$27M
Series A · Jun 2026
Between rounds
4.7 years
from the last two

The rounds

  1. Jun 2026
    Series A$27M2 new

    Source recorded

  2. Oct 2021

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Y CombinatorAccelerator1round
Kima VenturesVC firm1round
BoxGroupVC firm1round
Notion CapitalVC firm1round
EurazeoPrivate equity1round
Thibaud ElziereVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Hera

Who invested in Hera?

Hera's investors include Y Combinator, Kima Ventures, BoxGroup, Bain Capital Ventures and Notion Capital, and 2 more on record.

How much has Hera raised?

Hera has raised $29M across 2 rounds since 2021.

When did Hera last raise?

Hera's most recent round was a Series A of $27M in Jun 2026.

What was Hera's biggest round?

Its most recent round, $27M in Jun 2026, is also its largest on record.

Who backed Hera first?

Hera's first round on record, in Oct 2021, was backed by Y Combinator, Kima Ventures and Notion Capital and 2 others.

What stage is Hera at?

Hera's latest named round is a Series A, in Jun 2026.

Companies like Hera

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.